Literature DB >> 28141567

Blue Rubber Bleb Nevus Syndrome: Promising Response To Sirolimus.

Canan Akyuz1, Hilal Susam-Sen, Burca Aydin.   

Abstract

BACKGROUND: Blue rubber bleb nevus syndrome is a rare disease involving venous malformations. CASE CHARACTERISTICS: We present a 6-year-old female with the syndrome, and consumptive coagulopathy. INTERVENTION/OUTCOME: After management with sirolimus, symptoms resolved. MESSAGE: Sirolimus may be a valuable option for reducing bleeding complications and cosmetic sequelae for the patients with this syndrome.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28141567     DOI: 10.1007/s13312-017-0998-1

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  4 in total

Review 1.  [Clinical effect of sirolimus in treatment of blue rubber bleb nevus syndrome in children: a report of 2 cases and literature review].

Authors:  Xu Quan; Chun-Di Xu; Ping Liu; Qing-Qing Zhang; Ye Chen; Le Wang; Yuan Xiao
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

2.  Blue rubber bleb nevus syndrome: Presentation of a case and review of the literature.

Authors:  Fabricio Andres Lasso Andrade; Jorge Alejandro Cadena Arteaga; Viviana Lizeth Echeverry Morillo; Ángela María Fajardo Arteaga; Jenny Alexandra Jurado Pantoja; Migdalia Zamirna Zuleny Lasso Anacona; Paula Andrea Nieto Lozano; Daniela Steffany Possos Obando; María Alejandra Palacios Rodríguez; Madelen Alexandra Ortiz Cárdenas; Hermes Albeiro Ortega Díaz; Diana Yulieth Ramírez Anacona; Rodrigo Zanabria Zarmienta
Journal:  Radiol Case Rep       Date:  2021-06-08

3.  Successful Management of Blue Rubber Bleb Nevus Syndrome (BRBNS) with Sirolimus.

Authors:  Ugochi O Ogu; Ghada Abusin; Rolla F Abu-Arja; Janice M Staber
Journal:  Case Rep Pediatr       Date:  2018-10-08

4.  Treatment of sirolimus in the pathological femoral fracture related to blue rubber bleb nevus syndrome: A case report.

Authors:  Yu-Jui Chang; Jih-Yang Ko; Jiunn-Ming Sheen; Ka-Kit Siu
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.